
In Ireland, an asthma management pilot suggests pharmaceutical companies need to start thinking more creatively about market access.
(Nov 26, 2009)How to create unified market access strategies by fostering inter-departmental collaboration
(Dec 14, 2009)Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report.
(Jan 28, 2010)Peter Mansell reports on the changing role of pharmacists in promoting adherence.
(Feb 9, 2010)Peter Mansell reports on how pharmacoeconomics can help define data requirements to match market access plans.
(Feb 25, 2010)Peter Mansell investigates how pharma companies can use Web-based media to improve adherence and become part of the treatment decision-making process.
(Apr 6, 2010)Peter Mansell talks to Kevin Norell, senior vice president of advanced methods at Kantar Health, about the need to stay flexible with market forecasts.
(Apr 13, 2010)Peter Mansell explains why the pharma industry needs to reclaim data ownership in ways that promote both transparency and market opportunity.
(Apr 19, 2010)Peter Mansell explores the new partnerships and new models needed to assure successful market access strategies.
(Apr 20, 2010)Kevin Appareti, global director for Medical Science Liaison at Philips Healthcare, explains how to motivate KOLs and how to measure their value
The Mobile Health Competition is now closed, but the journey is just beginning for the winning idea.
Phil Taylor reports on the commercial and scientific opportunities facing medical scientific liaisons (MSLs)
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs